• Weiss-Jared-Faculty-Profile

    Weiss Appointed Principal Investigator for Advancing PDS Biotech Combination Studies in Head, Neck and HPV-related Advanced Cancer

    Jared Weiss, MD, associate professor of medicine in the division of hematology and oncology, and researcher with UNC Lineberger Cancer Center, will lead an advancing Phase 2 study that evaluates the efficacy and safety of PDS Biotech’s Versamune®-based immunotherapy, PDS0101–in combination with Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab)–in the first-line treatment of … Continued

  • thomson-reuters

    Six Medicine Faculty Recognized for Highly Cited Research

    Six UNC Department of Medicine faculty members were named in the 2019 Thomas Reuters List of Highly Cited Researchers. The annual list recognizes the most influential researchers of the past decade, demonstrated by the production of multiple highly-cited papers than rank in the top 1% by citations for field and year in Web of Science. The following medicine faculty are listed: Jo … Continued

  • Katherine Reeder-Hayes, MD

    “Know Your Girls” campaign draws attention to racial differences related to breast cancer

    A new campaign aims to reduce the black women mortality rate from breast cancer by 25 percent over five years, in 10 US communities. Katherine Reeder-Hayes, MD, in the division of hematology and oncology was interviewed for this WRAL news story, recognizing black women are 40 percent more likely to die from breast cancer than white women.

  • luis-malpica-castillo

    Patients with blood disorders don’t receive recommended vaccines and screenings

    (Republished from the UNC Health Care and UNC School of Medicine Newsroom) New research from the University of North Carolina School of Medicine has found that only a low percentage of hospital patients being treated for immune-mediated blood disorders, such as immune thrombocytopenic purpura, receive the recommended vaccinations and infectious disease screenings. “The management … Continued

  • Nigel Key, MD

    Medicine introduces new multi-disciplinary blood research center

    The UNC Department of Medicine announces the formation of the new UNC Blood Research Center (UNC BRC), administratively housed within the division of hematology and oncology. With faculty participation from medicine, pediatrics, pathology and biochemistry, the Center will promote basic and clinical research in non-malignant blood disorders, building on ground-breaking discoveries … Continued

  • stephan-moll

    Moll discusses athlete-blood clot connection in UNC Health Talk

    Stephan Moll, MD, professor of medicine in the division of hematology and oncology, specializes in coagulation and classical hematology, with a focus on thrombosis and anticoagulation. Moll was recently interviewed by UNC Health Talk about the athlete-blood clot connection where he explained how blood clots develop and how the condition affects athletes.

  • Matthew Painschab, MD

    Featured Physician: Matthew Painschab, MD

    Dr. Matthew Painschab originally thought he would become a lawyer, but a physiology course in college changed his mind. The ability to explain medical phenomena and the research that goes into it attracted him to medicine. Dr. Painschab says the best advice he’s ever received is to approach life the way a cat does, with a consciousness largely of now.

  • Lisa Carey, MD

    Carey, one of three UNC researchers to receive Susan G. Komen funding

    (Excerpt republished from the UNC Health Care and UNC School of Medicine Newsroom) Komen Scientific Advisory Board Member Lisa Carey, MD, will receive $400,000 to study how HER2+ tumors respond to HER2-targeted therapies. This project will integrate and analyze data from more than 1,300 women participating in six neoadjuvant, first step treatment, clinical trials of HER2- targete … Continued

  • Nigel S. Key, MB, ChB, FRCP

    Key publishes practice guideline updates for venous thromboembolism prophylaxis

    Nigel S. Key, MB, ChB, FCRP, chief of hematology in the division of hematology and oncology, recently published practice guideline updates for venous thromboembolism prophylaxis (VTE) for patients in the Journal of Clinical Oncology.  In these updates, Key recognizes that direct oral anticoagulants have been added as options for treating VTE prophylaxis in patients with cancer. K … Continued

  • crispr-image

    Little Considers Benefits and Risks of Treating Sickle Cell Patients with CRISPR Gene-Editing

    A new CNN health story features Jane Little, MD, professor of medicine in the division of hematology and oncology, discussing how CRISPR gene-editing technology could impact patients in a new study of adults with severe sickle cell disease. Little specializes in improving care for sickle cell patients and helping them manage their conditions.